Matt French

494 total citations
15 papers, 346 citations indexed

About

Matt French is a scholar working on Surgery, Transplantation and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Matt French has authored 15 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 5 papers in Transplantation and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Matt French's work include Renal Transplantation Outcomes and Treatments (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Matt French is often cited by papers focused on Renal Transplantation Outcomes and Treatments (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Matt French collaborates with scholars based in United Kingdom and United States. Matt French's co-authors include J. R. Batchelor, Peter J. Morris, A. Ting, Christopher J. Luscombe, Mark F. Saxby, Peter W. Jones, Anthony A. Fryer, Richard C. Strange, Hugo Burgos and T. Chard and has published in prestigious journals such as The Lancet, The Journal of Urology and British Journal of Cancer.

In The Last Decade

Matt French

15 papers receiving 290 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matt French United Kingdom	12	130	124	124	56	35	15	346
Xiao-Jing Zuo United States	12	211 1.6×	137 1.1×	154 1.2×	83 1.5×	19 0.5×	19	441
Ali‐Reza Biglarnia Sweden	7	201 1.5×	135 1.1×	101 0.8×	39 0.7×	50 1.4×	20	376
Saskia Merkel Germany	6	81 0.6×	61 0.5×	60 0.5×	61 1.1×	17 0.5×	9	356
Navdeep Nayyar United States	8	126 1.0×	60 0.5×	56 0.5×	72 1.3×	17 0.5×	10	339
Helga Smit France	8	78 0.6×	73 0.6×	313 2.5×	95 1.7×	10 0.3×	11	548
Qiuxia Mao China	8	153 1.2×	214 1.7×	86 0.7×	45 0.8×	34 1.0×	15	380
E. Stephanian United States	13	384 3.0×	138 1.1×	29 0.2×	68 1.2×	45 1.3×	25	575
Shinji Tomikawa Japan	11	69 0.5×	43 0.3×	27 0.2×	72 1.3×	21 0.6×	57	342
David Hooke Australia	6	31 0.2×	16 0.1×	131 1.1×	48 0.9×	15 0.4×	7	389
Veli Uysal Türkiye	12	101 0.8×	26 0.2×	35 0.3×	56 1.0×	47 1.3×	22	343

Countries citing papers authored by Matt French

Since Specialization

Citations

This map shows the geographic impact of Matt French's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matt French with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matt French more than expected).

Fields of papers citing papers by Matt French

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matt French. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matt French. The network helps show where Matt French may publish in the future.

Co-authorship network of co-authors of Matt French

This figure shows the co-authorship network connecting the top 25 collaborators of Matt French. A scholar is included among the top collaborators of Matt French based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matt French. Matt French is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Luscombe, Christopher J., Matt French, Mark F. Saxby, et al.. (2001). Prostate cancer risk: associations with ultraviolet radiation, tyrosinase and melanocortin-1 receptor genotypes. British Journal of Cancer. 85(10). 1504–1509. 55 indexed citations

Heifetz, Stephen A., Matt French, Maria Salete Nahás Pires Corrêa, & Jay L. Grosfeld. (1997). HEPATOBLASTOMA: The Indiana Experience with Preoperative Chemotherapy for Inoperable Tumors; Clinicopathological Considerations. Fetal and Pediatric Pathology. 17(6). 857–874. 1 indexed citations

Heifetz, Stephen A., Matt French, Maria Elvira Pizzigatti Corrêa, & Jay L. Grosfeld. (1997). Hepatoblastoma: The Indiana Experience with Preoperative Chemotherapy for Inoperable Tumors; Clinicopathological Considerations. Pediatric Pathology & Laboratory Medicine. 17(6). 857–874. 14 indexed citations

Heifetz, Stephen A., Matt French, Maria Salete Nahás Pires Corrêa, & Jay L. Grosfeld. (1997). HEPATOBLASTOMA: The Indiana Experience with Preoperative Chemotherapy for Inoperable Tumors; Clinicopathological Considerations. Pediatric Pathology & Laboratory Medicine. 17(6). 857–874. 5 indexed citations

Morris, Peter J., Laurence Chan, Matt French, & A. Ting. (1982). Low Dose Oral Prednisolone in Renal Transplantation. The Journal of Urology. 128(3). 660–660. 16 indexed citations

Williams, Keryn A., Matt French, A. Ting, D O Oliver, & Peter J. Morris. (1980). PEROPERATIVE BLOOD-TRANSFUSIONS IMPROVE CADAVERIC RENAL-ALLOGRAFT SURVIVAL IN NON-TRANSFUSED RECIPIENTS. The Lancet. 315(8178). 1104–1106. 27 indexed citations

Burgos, Hugo, Matt French, & J. R. Batchelor. (1974). HUMORAL AND CELL-MEDIATED IMMUNITY IN RATS WITH ENHANCED KIDNEY ALLOGRAFT,S. Transplantation. 18(4). 328–335. 12 indexed citations

Bowen, John E., J. R. Batchelor, Matt French, Hugo Burgos, & John W. Fabre. (1974). FAILURE OF ADOPTIVE IMMUNIZATION OR PARABIOSIS WITH HYPERIMMUNE SYNGENEIC PARTNERS TO ABROGATE LONG-TERM ENHANCEMENT OF RAT KIDNEY ALLOGRAFT,S. Transplantation. 18(4). 322–327. 12 indexed citations

Batchelor, J. R., et al.. (1973). HYPERACUTE REJECTION AND ENHANCEMENT OF RABBIT-KIDNEY ALLOGRAFTS. The Lancet. 301(7807). 797–801. 9 indexed citations

10.

Fine, Richard Ν., J. R. Batchelor, Matt French, & Kenneth H. Shumak. (1973). THE UPTAKE OE 125I-LABELED RAT ALLOANTIBODY AND ITS LOSS AFTER COMBINATION WITH ANTIGEN. Transplantation. 16(6). 641–648. 12 indexed citations

11.

French, Matt & J. R. Batchelor. (1972). Enhancement of Renal Allografts in Rats and Man. Immunological Reviews. 13(1). 115–141. 26 indexed citations

12.

French, Matt. (1972). THE EARLY EFFECTS OF ALLOANTIBODY AND COMPLEMENT ON RAT KIDNEY ALLOGRAFTS. Transplantation. 13(5). 447–451. 20 indexed citations

13.

French, Matt, J. R. Batchelor, & Hugh G. Watts. (1971). THE CAPACITY OF LYMPHOCYTES FROM RATS BEARING ENHANCED KIDNEY ALLOGRAFTS TO MOUNT GRAFT-VERSUS-HOST REACTIONS. Transplantation. 12(1). 45–48. 13 indexed citations

14.

French, Matt & J. R. Batchelor. (1969). IMMUNOLOGICAL ENHANCEMENT OF RAT KIDNEY GRAFTS. The Lancet. 294(7630). 1103–1106. 105 indexed citations

15.

Chard, T., Matt French, & J. R. Batchelor. (1967). ENHANCEMENT OF THE C57BL LEUKEMIA E.L.4 BY FAB FRAGMENTS OF ISOANTIBODY. Transplantation. 5(5). 1266–1272. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact